Trial intelligence / Profile preview

Phase 2 Trial of DA-8159 (Udenafil) in Erectile Dysfunction

NCT00282607Phase 2Completed

Sponsor
Dong-A Pharmaceutical
Start
May 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of udenafil in erectile dysfunction (ED), sponsored by Dong-A Pharmaceutical. Started May 2005; status: completed.

02

Drugs

udenafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT00282607.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00282607.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call